Overview

Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
To investigate whether treatment with a vitamin-D receptor activator is able to improve important markers of cardiovascular risk.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Danderyd Hospital
Collaborator:
Abbott
Treatments:
Ergocalciferols
Vitamin D
Vitamins